Clinical Trial Update: 29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness

View source ↗

Summary

This clinical trial update describes a study on a 29-gene liver cancer subtype and immunotherapy in hepatocellular carcinoma, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Junjie Xu | Conditions: Primary Hepatocellular Carcinoma | Status: NOT_YET_RECRUITING